These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23301711)

  • 21. Value in Oncology: It Is in the Eyes of the Beholder.
    Nabhan C; Phillips EG; Feinberg BA
    J Natl Compr Canc Netw; 2019 Jan; 17(1):2-5. PubMed ID: 30659123
    [No Abstract]   [Full Text] [Related]  

  • 22. National cancer director responds on top-up payments.
    Richards M
    BMJ; 2008 Jul; 337(7661):a686. PubMed ID: 18614496
    [No Abstract]   [Full Text] [Related]  

  • 23. Trends in the Cost of Cancer Care: Beyond Drugs.
    Laviana AA; Luckenbaugh AN; Resnick MJ
    J Clin Oncol; 2020 Feb; 38(4):316-322. PubMed ID: 31804864
    [No Abstract]   [Full Text] [Related]  

  • 24. In Cancer Care, Can We Afford To Hope?
    Hafner Z
    Manag Care; 2018 May; 27(5):31. PubMed ID: 29763406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Key factors impacting the delivery and financing of oncology care in the United States.
    Goldsmith PJ; Paivanas T
    J Natl Compr Canc Netw; 2006 May; 4(5):434-7. PubMed ID: 16715607
    [No Abstract]   [Full Text] [Related]  

  • 26. Perspectives on Cost and Value in Cancer Care.
    Saltz LB
    JAMA Oncol; 2016 Jan; 2(1):19-21. PubMed ID: 26501848
    [No Abstract]   [Full Text] [Related]  

  • 27. Oncology drug costs-the imaginary crisis?
    Turck R
    Ann Oncol; 2017 Feb; 28(2):427-431. PubMed ID: 27771612
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug pricing should depend on shared values.
    Ramsey S
    Nature; 2017 Dec; 552(7685):S78. PubMed ID: 29293242
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug Pricing Trends for Orally Administered Anticancer Medications Reimbursed by Commercial Health Plans, 2000-2014.
    Dusetzina SB
    JAMA Oncol; 2016 Jul; 2(7):960-1. PubMed ID: 27123993
    [No Abstract]   [Full Text] [Related]  

  • 30. Does evidence-based medicine really reduce costs?
    Kolodziej MA
    Oncology (Williston Park); 2011 Mar; 25(3):214, 218. PubMed ID: 21548463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bending the cost curve in cancer care.
    Good M; Good CB
    N Engl J Med; 2011 Aug; 365(7):674-5; author reply 675-6. PubMed ID: 21848478
    [No Abstract]   [Full Text] [Related]  

  • 32. The UK Cancer Drugs Fund Experiment and the US Cancer Drug Cost Problem: Bearing the Cost of Cancer Drugs Until It Is Unbearable.
    Prasad V; Mailankody S
    Mayo Clin Proc; 2016 Jun; 91(6):707-12. PubMed ID: 27261866
    [No Abstract]   [Full Text] [Related]  

  • 33. SPIKE$: a six-step protocol for delivering bad news about the cost of medical care.
    McFarlane J; Riggins J; Smith TJ
    J Clin Oncol; 2008 Sep; 26(25):4200-4. PubMed ID: 18757335
    [No Abstract]   [Full Text] [Related]  

  • 34. Seeking value as cancer drug costs soar.
    Bender E
    Cancer Discov; 2013 Aug; 3(8):833-4. PubMed ID: 23928760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value-based insurance design yields near- and long-term improvements in medication adherence.
    Collado M
    Find Brief; 2013 Mar; 16(1):1-3. PubMed ID: 23539769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient costs on clinical trials.
    Presant CA
    J Natl Cancer Inst; 2000 Sep; 92(17):1441-3. PubMed ID: 10974083
    [No Abstract]   [Full Text] [Related]  

  • 37. Cost to the NHS of Roche oncology treatments.
    Atkins M
    J R Soc Med; 2007 Jul; 100(7):303. PubMed ID: 17606744
    [No Abstract]   [Full Text] [Related]  

  • 38. Communicating with patients about chemotherapy costs.
    de Lemos ML
    J Clin Oncol; 2007 May; 25(15):2142; author reply 2142. PubMed ID: 17513825
    [No Abstract]   [Full Text] [Related]  

  • 39. Multimodality cancer care and implications for episode-based payments in cancer.
    Gondi S; Wright AA; Landrum MB; Zubizarreta J; Chernew ME; Keating NL
    Am J Manag Care; 2019 Nov; 25(11):537-538. PubMed ID: 31747230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monthly and Median Costs of Cancer Drugs at the Time of FDA Approval 1965-2016.
    J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 29117395
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.